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Abstract
Rotator cuff tear is the most frequent tendon injury in the adult population. Despite current
improvements in surgical techniques and the development of grafts, failure rates following
tendon reconstruction remain high. New therapies, which aim to restore the topology and
functionality of the interface between muscle, tendon and bone, are essentially required.
One of the key factors for a successful incorporation of tissue engineered constructs is a
rapid ingrowth of cells and tissues, which is dependent on a fast vascularization. The dorsal
skinfold chamber model in female BALB/cJZtm mice allows the observation of microhemo-
dynamic parameters in repeated measurements in vivo and therefore the description of the
vascularization of different implant materials. In order to promote vascularization of implant
material, we compared a porous polymer patch (a commercially available porous polyure-
thane based scaffold from Biomerix™) with electrospun polycaprolactone (PCL) fiber mats
and chitosan-graft-PCL coated electrospun PCL (CS-g-PCL) fiber mats in vivo. Using intra-
vital fluorescence microscopy microcirculatory parameters were analyzed repetitively over
14 days. Vascularization was significantly increased in CS-g-PCL fiber mats at day 14 com-
pared to the porous polymer patch and uncoated PCL fiber mats. Furthermore CS-g-PCL
fiber mats showed also a reduced activation of immune cells. Clinically, these are important
findings as they indicate that the CS-g-PCL improves the formation of vascularized tissue
and the ingrowth of cells into electrospun PCL scaffolds. Especially the combination of
enhanced vascularization and the reduction in immune cell activation at the later time points
of our study points to an improved clinical outcome after rotator cuff tear repair.
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Introduction
Rotator cuff tears are common injuries in human shoulders. Especially degenerative processes
in elderly people account for a large number of injuries, so that about 50% of people over their
seventies are affected by a rotator cuff tear [1]. Depending on the extent of the tear, the symp-
toms include pain, reduced function and weakness. Especially lateral abduction of the affected
arm causes severe pain, which persists even throughout the night while resting [2]. Frequently,
changes in the musculotendinous unit occur between the onset of the rotator cuff tear and the
time of diagnosis. The loss of muscle activity thereby leads to muscle atrophy and the loss of
pretension entails fatty infiltration of the musculature [3,4]. As a result tendon retraction
arises, as well as loss of elasticity in the musculotendinous unit [5]. These changes complicate
or in some cases hinder surgical fixation of the tendon to the osseous attachment. The main
problem after surgery is the healing process after tendon reconstruction, because instead of a
regenerated tendon-bone-junction [6] the formation of scar tissues, which show reduced ten-
sile strength compared to the intact tendon, can be observed [7]. For regeneration of tendon
defects, different graft materials and surgical techniques were developed to support tendon
healing [6], but neither special techniques nor different graft materials are able to improve the
prognosis after tendon reconstruction significantly. Furthermore, also after successful refixa-
tion a reduced tendon strength compared to healthy tendons can be observed [8] and failure
rates after tendon reconstruction remain unacceptably high. The high incidence of failure
related to existing implant materials and repair techniques emphasize the importance of func-
tional solutions for tendon repair [9].
Implants that facilitate an effective surgical treatment of rotator cuff tears ideally mimic the
biological and biomechanical characteristics of the intact tendon and at the same time do not
hinder the natural healing process. A key prerequisite for a successful implant material is the
rapid ingrowth of cells and tissues for the development of a regenerated tendon-bone-transi-
tion. Ingrowth of cells and tissues thereby strongly depends on a fast vascularization of the
implant material for transporting nutrients, growth factors, and supporting gas exchange and
removal of waste materials. Implant failure is often attributable to insufficient tendon healing,
mainly depending on insufficient vascularization [10,11]. Potential candidates to fulfill these
criteria are electrospun fiber mats, which are already often used in tissue engineering applica-
tions [12]. Polycaprolactone (PCL) is applicable in this field because of its adequate mechanical
properties, its biocompatibility and slow degradation in vivo [13]. However, its hydrophobic
nature interferes with cell attachment and growth [14]. Recently it was shown that electrospun
PCL fiber mats with a CS-g-PCL coating are more hydrophilic and provide cellular recognition
sites, which create an attractive surface for initial cell attachment [15,16].
In recent decades biodegradable polymers, like PCL, have become increasingly important.
PCL has a wide range of application in tissue engineering including vascular grafts [17], bone
[18,19], cartilage [20], liver [21], bladder [22], skin [23] and nerve [24]. Implants for rotator
cuff tear repair should have a positive impact on tendon healing by supporting cellular infiltra-
tion and guiding the regeneration of an organized tendon structure. These positive effects
could be shown for nanofibrous PCL based scaffolds in an in vivomodel in rats for primary
rotator cuff repair [25]. Electrospun PCL fiber mats are particularly suited as an implant for
rotator cuff tear repair as they can easily be produced with variable fiber arrangements. By fab-
rication of fiber mats with directed or undirected fiber orientation they can be adopted to the
microarchitecture of the different sections of the native tendon. The specific design of the fiber
mat in turn stimulates the regeneration of organized tendon structures. In a previous study we
analyzed electrospun PCL fiber mats with undirected fiber orientation, that were intended to
mimic the specific fiber orientation at the tendon-bone transition in the femur chamber in rats
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[26]. In this study fiber mats with directed fiber structures were used to simulate the tendon-
muscle transition. These electrospun PCL fiber mats are intended to form the lead structure
for the transition zone of the rotator cuff.
Different studies investigated the physical, chemical and biological characteristics of scaf-
fold devices for rotator cuff repair [27], but data describing the vascularization of electrospun
PCL fiber mats are limited. For characterization of the early vascularization of electrospun
PCL implant materials the dorsal skinfold chamber in mice was used in the present study. This
in vivo model allows the repetitive observation of the vascularization of different implant
materials by means of intravital fluorescence microscopy [28]. The aim of this study was to
compare microhemodynamic parameters inside electrospun PCL based implants as described
above with the microhemodynamic parameters of a reticulated polyurethane based scaffold




Electrospun polycaprolactone fiber mats with aligned fibers were produced as described else-
where [30]. Briefly, a poly-ε-caprolactone solution of 170 mg/ml (Mn = 80.000 g/mol, Sigma-
Aldrich Chemie GmbH, Taufkirchen, Germany) (PCL) and trifluoroethanol (TFE, abcr
GmbH, Karlsruhe, Germany) was used to produce electrospun PCL fiber mats. The scaffolds
were produced with a collector speed of 8 m/s, which resulted in orientated fibers. The voltage
was set to 25 kV and the emitter to collector distance to 25 cm. By using a flow rate of 4 ml/h 8
ml polymer solution resulting in fiber mats with a thickness of approximately 200 μm.
Experimental groups were unmodified PCL fiber mats and PCL fiber mats modified with a
fiber coating utilizing a graft copolymer consisting of chitosan and polycaprolactone, called
CS-g-PCL [31]. As a control group a commercially available porous polyurethane based scaf-
fold (Biomerix RCR Patch, Biomerix Corporation, Somerset, USA; purchased from Cellon,
Bascharage, Luxembourg), was used [29,32].
For sterilization all implants were cut into pieces of 3 mm x 5 mm and shrink-wrapped in
sterilization pouches (SteriClin, Vereinigte Papierwarenfabriken, Feuchtwangen, Germany).
Sterilization was performed by beta radiation with a dose of 25 kGy (using a Rhodotron TT
100 e-beam accelerator, Mediscan, Kremsmünster, Austria).
Evaluation of porosity and pore diameter
Gravimetric method was used to determine the porosity of the fibrous scaffolds by using the
mass, density and dimensions of a sample. The pore diameter was determined with a capillary
flow porometer (3 Gzh, Quantachrome GmbH & Co.KG). This characterization technique
based on the displacement of a wetting liquid (Porofil1, Quantachrome GmbH & Co. KG)
from the pores of the sample by increasing the pressure from an inert gas. The underlying
equations for the calculation of the porosity and the pore diameter were described elsewhere
[26]. The porosity and the pore diameter of the reticulated polyurethane based scaffold was
evaluated in a previous study [26].
Experimental protocol
For intravital fluorescence microscopy, a total of 24 BALB/cJZtm mice were equipped with
dorsal skinfold chambers. Scaffolds, consisting of either porous polymer patch (control)
(n = 8) or unmodified PCL fiber mats (n = 7) or chitosan coated PCL fiber mats (n = 9), were
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implanted into the dorsal skinfold chamber. Intravital fluorescence microscopy analysis of vol-
umetric blood flow, wall shear rate, leukocyte-endothelial cell interaction, macromolecular
leakage and functional capillary density were performed immediately as well as 3, 6, 10 and 14
days after implantation.
Animals
All experiments were conducted in accordance with the German legislation for the protection
of animals and the Guide for the Care and Use of Laboratory Animals (8th edition, 2011). The
experiments were approved by the competent authority (Niedersächsisches Landesamt für
Verbraucherschutz und Lebensmittelsicherheit, reference number 33.12-42502-04-15/2015).
Female BALB/cJZtm mice (Central animal facility, Hannover Medical School) with an age of
12 to 18 weeks and a body weight of 22.5 g ± 1.9 g were used for the study. All animals were
housed individually per cage at room temperature between 22˚C and 24˚C and a relative
humidity of 60–65% with a 12-hour day-night cycle. The mice had free access to tap water and
standard pellet food (1328 Hybridpellet, Altromin, Lage, Germany) at all times.
Anesthesia
The preparation of the dorsal skinfold chamber and repeated intravital fluorescence micros-
copy were executed under inhalational anesthesia (EZ-7000 Classic System, PLEXX, Elst, The
Netherlands) by isoflurane (Isofluran CP1, cp pharma, Burgdorf, Germany). After the ani-
mals were placed in an induction chamber anesthesia was induced with 5% isoflurane until
loss of righting reflex. The anesthesia depth was determined with the aid of the toe pinch. After
induction the animals were placed in appropriate position on a heating mat to protect them
against hypothermia. Animals remained anesthetized with the aid of a nose cone with 2–3%
isoflurane in oxygen.
Preparation of the dorsal skinfold chamber
The dorsal skinfold chamber in mice is an accepted model to investigate changes of the micro-
circulation and the biocompatibility of a given material [33]. The chamber is constructed of
two symmetrical frames and has an observation window with 12 mm diameter (Fig 1). The
preparation of the dorsal skinfold chamber has been described in detail previously [34,35].
Briefly, after preparation of the skin the frames were implanted on the extended dorsal skinfold
of the mice, so that the skin was double-layered between the frames. One layer of skin includ-
ing cutis, subcutis, musculus panniculus carnosus, and the two layers of the musculus retractor
was completely removed by dissection in a circular area with a diameter of 12 mm, exposing
the musculus panniculus carnosus of the opposite skin layer. The exposed tissue layer was cov-
ered with a coverslip that was secured with a circlip. Postoperatively, the animals were given
three days for convalescence and adaption to the dorsal skinfold chamber before the implant
material was tested in vivo. For implantation the coverslip was removed and the implant mate-
rial was inserted in the center of the observation window. The mice were treated with antibiot-
ics (Enrofloxacin 5 mg/kg, Baytril 25 mg/ml, Bayer, Leverkusen, Germany) intraoperatively
and per os for seven days after surgery. Analgesics (Carprofen, 5 mg/kg, Rimadyl 50 mg/ml,
Pfizer Deutschland GmbH, Berlin, Germany) were given intraoperatively and for two days
after surgery. During the experimental period the animals were evaluated daily with a score
based evaluation system including the assessment of weight loss, general condition, spontane-
ous behavior, clinical findings and lameness.
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Intravital fluorescence microscopy and analysis of microcirculatory
parameters
Intravital fluorescence microscopy was performed as described in Gniesmer et al., 2019 [26].
The recorded data was analyzed using the image analysis software CapImage (CapImage 8.6.3,
Zeintl, Heidelberg, Germany). Briefly leukocyte-endothelial cell interactions, microhemody-
namics, and macromolecular leakage were measured in four different regions of interest in the
border zone of the scaffold. In each region of interest one venule in the granulation tissue
around the implant (inner diameter: 20–40 μm) was selected and observed over 20 seconds for
evaluation of vessel diameter, red blood cell velocity, wall shear rate and macromolecular leak-
age. The leukocytes were classified according to their interaction with the vascular endothe-
lium as adherent (they that did not move or detach from the endothelial lining within an
observation period of 20 s), rolling (moving cells with a velocity less than two-fifth of the cen-
terline velocity) or free flowing cells. Microvessel density, defined as the length of blood vessels
per area of observation given in cm/cm2, was measured in the periphery around the implant
and in the center of the implant. Both values were displayed as the total functional capillary
density expressed as the sum of peripheral and central functional capillary density. For a full
description of the data analysis refer to Gniesmer et al., 2019 [26].
Histology and immunohistochemistry
After the experimental period of 14 days, animals were finalized via cervical dislocation under
deep anesthesia and histological examinations were performed. Formalin-fixed specimens of
the dorsal skinfold chamber were embedded in paraffin for light microscopy according to
standard procedures. Thin sections (5 μm) were stained with hematoxylin (Merck KGaA,
Fig 1. Dorsal skinfold chamber. Two symmetrical steel frames are connected via screws with a gap nut in between. The observation window (Ø 12 mm) is covered
with a coverslip, which is fixed by a circlip. Recesses reduce the weight of the chamber.
https://doi.org/10.1371/journal.pone.0227563.g001
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Darmstadt, Germany) and eosin (Merck KGaA, Darmstadt, Germany) according to standard
procedures and examined by light microscopy (Leica DM4000 B, Leica Mikrosysteme, Wet-
zlar, Germany).
Van Gieson staining of thin sections (5 μm) with hematoxylin and picrofuchsia acid solu-
tion (Merck KGaA, Darmstadt, Germany) according to standard procedures was applied to
detect collagen fibers. All specimens were examined by light microscopy (Leica DM4000 B,
Leica Mikrosysteme, Wetzlar, Germany).
For detection of capillaries, endothelial cells were immunohistochemically stained using a
rabbit anti-mouse CD31 antibody (LifeSpan Biosciences, Seattle, USA purchased from BIO-
ZOL Diagnostica Vertrieb GmbH, Eching, Germany); a rat anti-mouse CD68 antibody (Acris
Antibodies GmbH, Herford, Germany) was used to detect macrophages; a rabbit anti-mouse
CSF1R antibody (OriGene Technologies, Inc., Rockville, USA) was used for detection of mac-
rophages in general; a rat anti-mouse CD86 antibody (OriGene Technologies, Inc., Rockville,
USA) was used to detect macrophages with predominantly pro-inflammatory actions; a rabbit
anti-mouse CD11b antibody (OriGene Technologies, Inc., Rockville, USA) was used to detect
monocytes and a rat anti-mouse CD3 antibody (OriGene Technologies, Rockville, Inc., USA)
was used to detect T-cells.
As secondary antibodies a biotin conjugated goat anti-rabbit antibody and a biotin conju-
gated goat anti-rat antibody (both from Dianova, Hamburg, Germany), respectively were
used. After incubation with streptavidin conjugated horseradish peroxidase (Dianova, Ham-
burg, Germany) color development with the addition of 3.3´-diaminobenzidine (DAB) (Vec-
tor Laboratories, Inc., Burlingame, CA, USA) was monitored microscopically followed by
counterstaining with hematoxylin. For immunofluorescence detection an Alexa Fluor1
488-conjugated goat anti-rat antibody and an Alexa Fluor1 488-conjugated goat anti-rabbit
antibody (both Dianova, Hamburg, Germany), respectively was used. Nuclei were stained
using DAPI (Carl Roth GmbH, Karlsruhe, Germany). By omitting the primary antibody nega-
tive controls were performed, which all showed no detectable staining. All specimens were
examined by fluorescence microscopy (Leica DM4000 B, Leica Mikrosysteme, Wetzlar,
Germany).
The software celISens Dimensions 1.14 (Olympus Deutschland GmbH, Hamburg, Ger-
many) was used to quantify the immunofluorescence detection of macrophages, monocytes
and T-cells. Using a magnification of 20x the area of green fluorescence was measured and
normalized using the area of blue fluorescence (nuclei).
Neutrophilic granulocytes were detected by naphtol-AS-D-chloroacetate esterase staining
as described in Willbold et al., 2013 [36].
Statistics
Results are expressed as means ± standard error of the mean (SEM). Differences between
groups were assessed by one-way analysis of variance (ANOVA) and differences within groups
were analyzed by one-way repeated measures ANOVA. To identify differences between pairs
of groups, Student-Newman-Keuls post-hoc tests were performed. Differences were consid-
ered significant at p< 0.05. All data were analyzed using the GraphPad Prism software (Ver-
sion 7.0).
Results
Properties of the material
To compare and evaluate them towards the desired biological performance the porosity and
the pore diameter of the various implant materials were examined (Fig 2). The control
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polyurethane material exhibited very large pore sizes of up to 175.34 μm and a porosity of
94.7% [26]. It was found that the pure PCL had a porosity of 93.67%. The pore size (maximum
diameter 11.5 μm) was significantly lower than for the control group. Coating with the graft-
copolymer CS-g-PCL reduced the porosity to 81.79% and simultaneously increased the fiber
diameter by 0.45 μm, resulting in a maximum pore diameter of 7.56 μm (Table 1).
Animals
The animals tolerated the chamber well and showed no signs of discomfort or changes in
behavior. The control group and the group with CS-g-PCL lost three animals each. The rea-
sons for the losses were very different. In the control group, one animal each was lost due to
anesthesia complications, through weight loss as well as through an injury in cage. In the CS-
g-PCL group, there were losses within the anesthesia, due to an inflammation at the chamber
as well as due to a necrosis of tail tip. There were no losses in the group with PCL. The lost ani-
mals were not included in the statistical evaluation.
Microhemodynamic parameters
Overall, data indicated that the microvascular blood flow of host tissue was not impaired upon
implantation of the different materials. Venular diameters stayed constant in all experimental
groups ranging between 19 and 26 μm (Table 2). Volumetric blood flow and wall shear rates of
venules were not significantly altered (Table 2).
Functional capillary density
Within the first three days after implantation, all implants provoked an angiogenic response of
the host striated muscle tissue. Quantitative analysis revealed a progressive increase in the
Fig 2. Scanning electron microscopy of the implant materials. Porous polymer patch (A), unmodified PCL fiber mat (B) and PCL fiber mat modified with CS-g-PCL
(C). Scale bars: 200 μm (A), 100 μm (B, C).
https://doi.org/10.1371/journal.pone.0227563.g002
Table 1. Fiber diameter in μm, porosity in %, the maximum pore diameter in μm, the middle pore diameter in μm and the smallest pore diameter in μm of the con-
trol group scaffold (control; see Gniesmer et al., 2019), the unmodified PCL fiber mat group (PCL) and the PCL fiber mat modified with CS-g-PCL group.
control PCL CS-g-PCL
fiber diameter - 1.6 μm ± 0.7 μm 2.1 μm ± 0.6 μm
porosity 94.7% 93.7% 81.8%
Maximum pore diameter 175.3 μm 11.5 μm 7.6 μm
Middle pore diameter 139.4 μm 7.5 μm 5.7 μm
Smallest pore diameter 78.1 μm 6.1 μm 4.0 μm
https://doi.org/10.1371/journal.pone.0227563.t001
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group with the CS-g-PCL-coated fiber mat. At day three the angiogenic response in the control
group was comparatively high, but decreased over the evaluation period. Microvascular den-
sity showed constant data in the group of unmodified fiber mats. In contrast to the control
group and the unmodified fiber mat, the CS-g-PCL coated fiber mat showed significantly
increased angiogenesis 14 days after implantation (Table 3, Fig 3).
Inflammatory response
The implantation did not significantly increase the number of rolling leukocytes in all groups.
The rolling leukocytes were nearly constant in the control group and the CS-g-PCL group.
The PCL group showed a gradual increase of rolling leukocytes over the evaluation period.
The number of adherent leukocytes at the border zones of the implants decreased over the
evaluation period in all groups however, there were no significant differences detectable
between the groups over the observation period (Table 3, Fig 4).
Table 2. Venular diameters in μm, volumetric blood flow in pl/s and wall shear rate in s-1 of postcapillary and collecting venules at the border zones of the control
group scaffold (control), the unmodified PCL fiber mat group (PCL) and PCL fiber mat modified with CS-g-PCL group immediately (d0) and 3, 6, 10 and 14 days
after implantation. Values are expressed as means ± SEM.
Day 0 Day 3 Day 6 Day 10 Day 14
Diameter [μm]
control 24.0 ± 1.1 25.3 ± 1.2 24.7 ± 4.3 21.8 ± 3.7 26.0 ± 2.3
PCL 21.7 ± 1.5 22.2 ± 1.1 21.6 ± 1.0 18.9 ± 1.1 19.8 ± 1.4
CS-g-PCL 24.5 ± 1.8 23.3 ± 1.2 23.5 ± 2.3 21.3 ± 0.9 19.3 ± 1.5
Shear rate [s-1]
control 60.3 ± 9.5 68.2 ± 9.4 41.4 ± 5.4 53.8 ± 6.5 56.9 ± 12.2
PCL 80.0 ± 14.5 75.0 ± 11.9 72.5 ± 12.7 83.6 ± 6.5 83.3 ± 9.3
CS-g-PCL 67.4 ± 8.4 89.9 ± 15.1 74.7 ± 11.1 100.5 ± 10.0 112.1 ± 26.0
Volumetric blood flow [pl/s]
control 49.8 ± 6.2 59.5 ± 13.3 43.4 ± 10.3 39.6 ± 9.1 28.3 ± 11.2
PCL 56.1 ± 13.4 50.9 ± 10.6 44.4 ± 11.3 36.5 ± 7.0 41.4 ± 9.1
CS-g-PCL 69.1 ± 18.6 64.8 ± 8.5 57.0 ± 10.4 58.5 ± 5.1 50.4 ± 13.9
https://doi.org/10.1371/journal.pone.0227563.t002
Table 3. Functional capillary density in cm/cm2, number of rolling leukocytes in cells/min and number of adherent leukocytes in cells/mm2 at the periphery of the
control group scaffold (control), the unmodified PCL fiber mat group (PCL) and PCL fiber mat modified with CS-g-PCL group immediately (d0) and 3, 6, 10 and
14 days after implantation. Values are expressed as means ± SEM.
Day 0 Day 3 Day 6 Day 10 Day 14
Functional capillary density [cm/cm2]
control 202.4 ± 11.1 177.4 ± 33.4 129.6 ± 33.2 144.4 ± 35.3 77.5 ± 31.6
PCL 85.4± 15.5 98.0 ± 13.9 91.8 ± 16.9 67.1 ± 8.4 89.0 ± 16.7
CS-g-PCL 97.9 ± 13.0 103.1 ± 16.6 93.5 ± 20.7 101.0 ± 11.3 148.2 ± 41.7
Number of rolling leukocytes [cells/min]
control 3.6 ± 1.0 5.6 ± 2.1 5.0 ± 1.8 5.3 ± 2.1 3.8 ± 2.0
PCL 5.1 ± 1.9 5.3 ± 2.3 7.8 ± 2.4 12.0 ± 3.4 15.1 ± 4.7
CS-g-PCL 9.6 ± 4.3 11.0 ± 2.4 13.7 ± 3.1 11.2 ± 3.8 8.9 ± 3.8
Number of adherent leukocytes [cells/mm2]
control 358.4 ± 71.9 208.3 ± 44.2 337.9 ± 91.4 173.2 ± 73.4 100.7 ± 55.8
PCL 307.0 ± 97.8 276.8 ± 78.3 242.4 ± 122.9 50.0 ± 33.9 41.2 ± 29.8
CS-g-PCL 423.5 ± 129.2 360.8 ± 83.0 256.9 ± 71.9 80.1 ± 34.1 37.1 ± 24.4
https://doi.org/10.1371/journal.pone.0227563.t003
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Fig 3. Results of intravital microscopy. (A-C) Intravital microscopic overview images of control (A), PCL (B) and CS-g-PCL (C) at day 14. (D) Functional capillary
density in cm/cm2 in the border zones of the implants 0, 3, 6, 10 and 14 days after implantation. Means ± SEM; �p< 0.05 vs. PCL and CS-g-PCL; +p< 0.05 vs. PCL on the
same day;˚p< 0.05 vs. CS-g-PCL on the preceding time point. Scale bars: 400 μm.
https://doi.org/10.1371/journal.pone.0227563.g003
Fig 4. Leukocyte-endothelium interaction. Leukocyte-endothelium interaction at the periphery of the implants in
post-capillary and collecting venules after implantation. (A) Number of rolling leukocytes 0, 3, 6, 10 and 14 days after
implantation shown as number of cells/min. The implantation of different materials did not significantly increase the
number of rolling leukocytes. (B) Number of adherent leukocytes 0, 3, 6, 10 and 14 days after implantation as number
of cells/mm2. The number of adherent leukocytes at the border zones of the implants decreased over the evaluation
period.
https://doi.org/10.1371/journal.pone.0227563.g004
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Histology and immunohistochemistry
Hematoxylin-eosin-staining of sections from paraffin embedded specimen at day 14 showed
marked differences in cell ingrowth depending on the implant material. The porous polymer
patch was well infiltrated with cells throughout all regions of the scaffold (Fig 5A). The
ingrowth of cells was also detectable in specimens with PCL fiber mats, but to a lesser extent. A
cell-rich layer surrounding the PCL fiber mat was conspicuous in all specimens (Fig 5B). Also
in the CS-g-PCL group a cellular margin was found around the implant, but less pronounced
(Fig 5C). A comparable cell-rich layer around the implant was not detectable in the control
group (Fig 5A).
Immunohistochemical examination with a CD31 antibody for detection of vascular struc-
tures at day 14 was applied to verify the results obtained with intravital fluorescence micros-
copy (Fig 5G, 5H and 5I). The granulation tissue in the border zones of the implanted
materials was highly vascularized in all groups. However, endothelial cells were located in the
surroundings of the PCL fiber mats (PCL and CS-g-PCL) but not within them, as compared to
the control group where vascular structures were even detectable in the inside of implant
structure. Negative controls for immunohistochemical detection of CD31, which showed no
detectable staining, were performed by omitting the primary antibody (Fig 5J, 5K and 5L).
Collagen fibers were detectable in all groups by van Gieson staining. While in the control
group collagen fibers were visible around the implant structure (Fig 5D), in the groups with
Fig 5. HE staining, van Gieson staining and immunohistochemical detection of CD31. Representative histological stainings (A-I) 14 days after implantation into the
dorsal skinfold chamber of BALB/c mice. (A-C) HE staining (1) implant, (2) skin muscle, (3) subcutaneous tissue. (D-F) Collagen fibers were detected by van Gieson
staining (arrowheads). (G-I) The presence of endothelial cells and accordingly enhanced functional capillary density was confirmed by immunohistochemical detection
of CD31. (J-L) Negative controls. Areas of the implant are marked (#), arrows denote vascular structures. Scale bars: 100 μm (A—C), 50 μm (D—L).
https://doi.org/10.1371/journal.pone.0227563.g005
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the PCL fiber mats (PCL and CS-g-PCL) collagen fibers could be found just as a layer under-
neath the implant (Fig 5E and 5F).
The cellular composition of the cell-rich layer, which ensheathed the implants and the close
vicinity of the implants, was further characterized by means of naphtol-AS-D-chloroacetate
esterase staining and CD68 immunohistology (Fig 6). Chloroacetate-esterase positive
Fig 6. Naphtol-AS-D-chloroacetate esterase staining and immunohistochemical detection of CD68. Representative histological staining of neutrophilic
granulocytes (A-C) 14 days after implantation into the dorsal skinfold chamber of BALB/c mice using naphtol-AS-D-chloroacetate-esterase (CAE) staining.
Representative histological staining for detection of macrophages and monocytes (D-I) 14 days after implantation into the dorsal skinfold chamber of BALB/c
mice. (D-F) Immunohistochemical detection of CD68 for detection of macrophages. (G-I) Negative controls. Areas of the implant are marked (#).
https://doi.org/10.1371/journal.pone.0227563.g006
Table 4. Results from quantification of immunofluorescent detection of immune cell markers.
control PCL CS-g-PCL
CSF1R 0.070 ± 0.019 0.018 ± 0.005 0,029 ± 0,006
CD86 0.086 ± 0,020 0.031 ± 0.012 0.035 ± 0.011
CD11b 0.112 ± 0.036 0.018 ± 0.006 0.061 ± 0.022
CD3 0.072 ± 0.025 0.029 ± 0.015 0.020 ± 0.007
https://doi.org/10.1371/journal.pone.0227563.t004
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neutrophilic granulocytes were detectable in all groups including the porous polymer patch.
Although the neutrophilic granulocytes were detectable in all groups (Fig 6A, 6B and 6C), the
PCL fiber mats groups, especially those with unmodified PCL (Fig 6E) showed a high infiltra-
tion of this cell type. Similar results were found by CD68 immunohistochemistry for detection
of macrophages and monocytes (Fig 6D, 6E and 6F). Negative controls for immunohistochem-
ical detection of CD68, which showed no detectable staining, were performed by omitting the
primary antibody (Fig 6G, 6H and 6I).
Immunofluorescence staining of the marker proteins CSF1R, CD86, CD11b and CD3 were
performed to further characterize the immune response around the implant (Table 4, Fig 7).
By using these markers macrophages in general, macrophages with predominantly pro-
Fig 7. Immunofluorescence detection of CSF1R, CD86, CD11b and CD3. Representative histological stainings for detection of macrophages in
general, macrophages with predominantly pro-inflammatory actions, monocytes and T-cells (all green fluorescence) (A-C, E-G, I-K, M-O) 14 days
after implantation into the dorsal skinfold chamber of BALB/c mice. (A-C) Immunofluorescence detection of CSF1R for detection of macrophages
in general. (E-G) Immunofluorescence detection of CD86 for detection of macrophages with predominantly pro-inflammatory actions. (I-K)
Immunofluorescence detection of CD11b for detection of monocytes. (M-O) Immunofluorescence detection of CD3 for detection of T-cells. Nuclei
were stained using DAPI (blue fluorescence). Scale bars: 50 μm. (D,H,L,P) Quantitative analysis of cell infiltration by immunofluorescent staining
for CSF1R (D), CD86 (H), CD11b (L) and CD3 (P). All data are expressed as the fluorescence intensity of the marker of interest normalized to the
fluorescence intensity of DAPI staining. Values represent means ± SEM; �p< 0.05 vs. control and PCL; +p< 0.05 vs. control and CS-g-PCL.
https://doi.org/10.1371/journal.pone.0227563.g007
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inflammatory actions, monocytes and T-cells were detectable nearly in all groups, but overall
in a small extent. For all cell types, the control group showed the highest number of immune
cells. We quantified and normalized the immunofluorescence signals and found significant
differences for the respective immune cells. The detection of CSF1R and CD86 showed a sig-
nificant lower amount of macrophages and macrophages with predominantly pro-inflamma-
tory actions, respectively for both fiber mat groups. The detection of monocytes showed no
statistically significant differences, although we found a clear lower number of this cell type in
both fiber mat groups. The amount of the T-cell marker CD3 was clearly reduced in the PCL
group and statistically significant reduced in the CS-g-PCL group.
Discussion
One of the major challenges in the clinical application of implants is a fast and adequate vascu-
larization of the construct after insertion to guarantee oxygen supply, nutrition of cells and
removal of metabolites [10,33]. A lack or delay of angiogenesis and thus supply of nutrients is
a common reason for inadequate healing after surgery. Furthermore the poor development of
the microcirculation is known as a major problem in the integration of biomaterials [37]. As a
consequence, implants should be designed to cause early angiogenesis resulting in a fast vascu-
larization of the implant area and thereby promoting a fast and efficient regeneration. In con-
sideration of these circumstances it is reasonable to test new implant materials with regard to
vascularization and biocompatibility.
According to current knowledge, the main problem after rotator cuff tear repair is a high
prevalence of re-rupture due to variable structural healing [38]. Until now there are only lim-
ited options for therapy; in particular there are no implants available, which bridge the defect
site and facilitate the repair of tendon-bone-transitions. The critical step in creating a regener-
ated tendon-bone transition in rotator cuff tear repair is to achieve the functional integration
of the implant material in the host tissue during the healing process. The absence of blood ves-
sels in a repairing or metabolically active tissue may inhibit tissue repair; however, the rapid
ingrowth of cells and tissues is indispensable regarding the transport of nutrients, waste and
oxygen. To analyze microhemodynamic parameters on the muscle tissue over 14 days, the dor-
sal skinfold chamber is an ideal model. The implant material was tested in this soft tissue-
model based on a muscular structure, which allows repeated quantitative assessment of
implant vascularization in case of different applications, because the anatomical relationship
of the transition between tendon and muscle is readjusted [33,39].
Electrospun fiber mats made of PCL were used for the experimental groups. The biocom-
patibility of PCL is well known, but its mechanical strength is not sufficient for load bearing
applications [40]. Therefore, the electrospinning process was used to produce PCL fiber mats
with aligned fibers for higher mechanical strength [25]. As mentioned above the porosity and
pore size of the scaffold material is critical for ingrowth of capillaries, therefore based on the
decrease in pore size and porosity caused by the modification a reduced vascularization could
be anticipated for the CS-g-PCL coated samples. Furthermore chitosan is biocompatible and
biodegradable, therefore being well known as a biological material which promotes the healing
process of soft and hard tissues [41]. The immobilization of CS-g-PCL on top of electrospun
PCL fibers by crystallization resulted in the modification of all fibers also within the material
and not only on the surface like other techniques as e.g. plasma treatment [15].
The porous polymer patch, which was used as a control group in this study, has already
been tested for biocompatibility [7] and showed an improved outcome in a level IV clinical
study after augmentation surgeries [29]. Although the material characteristics of the porous
polymer patch differ considerably from that of the experimental groups, this material was
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selected as a control group as it has already been tested for the application of rotator cuff tear
in animal studies and a small retrospective case study [7,29,42].
Before using implant materials for clinical applications, the knowledge about vasculariza-
tion and biocompatibility is of great importance. Within the groups analyzed in our study we
observed different patterns of vascularization. The control group showed a rapid vasculariza-
tion and a high initial functional capillary density beginning with day three which declined at
the next two days and further declined at the end of the observation period. A similar vascular-
ization pattern can be observed during the healing of skin wounds. A histological analysis of
this process showed an initially high density of small caliber capillaries. With the ongoing heal-
ing of the wound the number of vessels declined and vessel caliber increased [43]. We think
that a comparable process accounts for the functional capillary density changes in our control
group. Therefore we can conclude, that we observed a fast and complete ingrowth of vascular-
ized tissue in the control scaffold. With respect to the CS-g-PCL group we think that angiogen-
esis and the growth of the granulation tissue is not that fast as it was observed in the control
group and therefore there is still an increase in functional capillary density at the end of the
observation period because tissue growth didn’t stopped until that time point. The most
important finding in this study was that CS-g-PCL coating improved the vascularization sig-
nificantly compared to unmodified PCL fiber mats and the porous polymer patch in the long
term. The significant increase in functional capillary density in PCL fiber mats with CS-g-PCL
modification is a very promising result, especially as in different studies an enhanced vasculari-
zation was described as beneficial for the healing of rotator cuff tears. In an experimental study
Harada et al. [44] used engineered cell sheets for the repair of resected infraspinatus tendons
in rats. After 8 weeks the authors found a significant higher ultimate failure load in the cell
sheet group compared the contralateral side which served as control without the implantation
of a cell sheet. This enhanced mechanical stability was the result of an improved healing pro-
cess which based on a higher vascularization of the repair site. An enhanced vascularization
may also be beneficial for rotator cuff tear repair in human patients. In a pilot trial Zumstein
et al. [45] used athroscopic repair of rotator cuff tears together with leukocyte- and platelet-
rich fibrin. This treatment resulted in a higher vascularization six weeks after repair. Fealy
et al. [46] also showed an enhanced vascularization immediately after rotator cuff repair by
ultrasound imaging. It has to be mentioned that in both studies vascularization decreased at
later time points and there were also no differences in clinical parameters at later time points.
Nevertheless it seems to be feasible to assume that an enhanced vascularization is beneficial for
the early stages of tendon healing after rotator cuff repair.
Recent studies demonstrated that vascularization of implants necessitates pores with a
diameter of at least 300 μm [47]. Qualitative histologic examinations showed that the porous
control polymer patch was well infiltrated with cells 14 days after implantation, because the
spongy structure of this scaffold facilitated cell infiltration (but failed to provide mechanical
stability). This finding was less apparent in the PCL fiber mats due to the denser structure
despite their good biocompatibility. Furthermore, the histologic examinations showed
capillaries in the inside of the control group in contrast to the PCL fiber mats, where the vascu-
lar structures were entirely limited to the outside of the implants. This result is attributable to
the different structures of both materials. While the porous polymer control patch has a porous
structure with an interconnected 3D network, which is favorable for cell ingrowth, the PCL
fiber mats showed smaller structural spaces due to the aligned fibers [48]. Although the porous
polymer patch improved biomechanical stability compared to controls without augmentation,
it did not achieve the desired stability of native tendon in biomechanical examinations [7]. An
optimal biomaterial should provide a porous texture, which is important for an adequate
nutritional supply to the cells and cell-to-cell interactions. Furthermore, the porosity has to be
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high enough to offer sufficient space for the sprouting of capillaries, cell proliferation, and inte-
gration into the surrounding tissue [47]. Therefore further developmental processes are neces-
sary to generate PCL fiber mats that allow a sufficient cellular ingrowth and vascular supply.
The modification of PCL with chitosan resulted in an improved in vitro cytocompatibility
compared to unmodified PCL [31]. The present study confirmed these data by in vivo data on
leukocytes and histological data. In particular, the increase in rolling leukocytes in the PCL
group is striking, while the values in the control group and the CS-g-PCL group remain nearly
constant. Still, all measured levels for leukocytes are comparatively low in this study [28,35].
In terms of histology the unmodified PCL showed a prominent cellular margin around the
implant. However, further characterization of this cell-rich layer around the implant showed
only slightly increased numbers of macrophages and neutrophilic granulocytes compared to
CS-g-PCL. The immunofluorescences even showed that significant fewer immune cells were
detectable in both PCL and CS-g-PCL than in the control group. In terms of biocompatibility
these results were promising especially for modified PCL fiber mats, as the porous polymer
patch had already been classified as biocompatible in recent studies [32]. With respect to the
short observation period, the collagen deposition did not allow any conclusion about a foreign
body reaction, although slightly more collagen fibers were detectable in the PCL group.
In conclusion our study showed that electrospun PCL fiber mats coated with a CS-graft-
PCL copolymer had a significant advantage for vascularization and biocompatibility of the
implant in contrast to unmodified PCL fiber mats, even though the porosity and pore size was
even smaller after modification with the graft-copolymer compared to unaltered PCL fiber
mats. Clinically, these are important findings as they indicate that the modification with chito-
san improves the formation of vascularized tissue and the ingrowth of cells. Furthermore the
combination of enhanced vascularization and the reduction in immune cell activation at the
later time points of our study points to an improved clinical outcome after rotator cuff tear
repair. Further investigations should be directed toward enlargement of pore size within the
fiber mats during their production to enhance subsequent cell ingrowth. In order to achieve
this aim one approach may be to enlarge the remaining space between the aligned fibers,
which can be achieved by increasing the fiber diameter [49].
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23. Dubský M, Kubinová Š, Širc J, Voska L, Zajı́ček R, Zajı́cová A, et al. Nanofibers prepared by needleless
electrospinning technology as scaffolds for wound healing. J Mater Sci Mater Med. 2012 Apr; 23
(4):931–41. https://doi.org/10.1007/s10856-012-4577-7 PMID: 22331377
24. Daud MFB, Pawar KC, Claeyssens F, Ryan AJ, Haycock JW. An aligned 3D neuronal-glial co-culture
model for peripheral nerve studies. Biomaterials. 2012; 33(25):5901–13. http://www.sciencedirect.com/
science/article/pii/S014296121200525X https://doi.org/10.1016/j.biomaterials.2012.05.008 PMID:
22656449
25. Beason DP, Connizzo BK, Dourte LM, Mauck RL, Soslowsky LJ, Steinberg DR, et al. Fiber-aligned
polymer scaffolds for rotator cuff repair in a rat model. J Shoulder Elb Surg. 2012 Feb 1 [cited 2018 Feb
27]; 21(2):245–50. https://www.sciencedirect.com/science/article/pii/S1058274611005180?via%
3Dihub
26. Gniesmer S, Brehm R, Hoffmann A, de Cassan D, Menzel H, Hoheisel A-L, et al. In vivo analysis of vas-
cularization and biocompatibility of electrospun polycaprolactone fiber mats in the rat femur chamber. J
Tissue Eng Regen Med. 2019 Apr 26;0(ja). https://doi.org/10.1002/term.2868
27. Ricchetti ET, Aurora A, Iannotti JP, Derwin KA. Scaffold devices for rotator cuff repair. J Shoulder Elb
Surg. 2012 Feb 1 [cited 2018 Feb 27]; 21(2):251–65. https://www.sciencedirect.com/science/article/pii/
S1058274611004812?via%3Dihub
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